Delivery Order SPE2DB22D2007-SPE2DB25FH8CX

Award Date 1/8/25
Potential Completion Date 1/30/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,270.30, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes, 0.3 ML, with a performance period ending on April 29, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a $3,837.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COMIRNATY 2024-25 (12Y UP) syringes, 0.3 mL, with an ultimate completion date of April 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,402.80 fixed-price contract is for the delivery of COMIRNATY COVID-19 vaccine syringes (0.3 mL) for ages 12 and up, with a performance period through February 4, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,220.84, is for the delivery of COMIRNATY 2024-25 (12 years and up) syringes in 0.3 mL size. The contract has a completion date of January 6, 2025 and uses a firm fixed-price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,402.80, is for the supply of COMIRNATY 2024-25(12Y UP) SYRG 0.3ML, a COVID-19 vaccine, with a period of performance through February 6, 2025. The contract is a Firm Fixed Price, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,716.35, is for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML, a vaccine product. The contract is a firm fixed-price delivery order with a completion date of May 14, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,714.08 and is for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML, which are COVID-19 vaccine syringes. The contract has an ultimate completion date of February 14, 2025 and is a Firm Fixed Price Delivery Order. This award is associated with a larger Indefinite Delivery Contract...
This is a $5,922.24 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML. The contract has an ultimate completion date of January 30, 2025. This award is under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,200.50, is for the delivery of COMIRNATY 2024-25 (12 years and up) syringes of 0.3 mL. The contract has a firm fixed price pricing type and a completion date of November 14, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML syringes. The $2,540.60 firm fixed-price contract has a completion date of June 16, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8CX
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,701.40 contract is for the delivery of COMIRNATY 2024-25 (12Y UP) 0.3ML syringes, which are likely COVID-19 vaccines. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 8, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:06 AM